HIV-1 Subtype A6 Infection: Clinical Trials

1 trial for HIV-1 Subtype A6 Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. .

Follow HIV-1 Subtype A6 Infection: new trials by email Literature Review of HIV-1 Subtype A6 Infection trials Research Report on HIV-1 Subtype A6 Infection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Long-Acting Cabotegravir and Rilpivirine in People Living With HIV-1 Subtype A6: A Real-World Retrospective Study
Cabotegravir Plus Rilpivirine Long-Acting Injectable - Human Immunodeficiency Virus (HIV)-1 Infection, HIV-1 Subtype A6 Infection
RecruitingPomeranian Medical University Szczecin2502026-05-122026-06-11

Narrower conditions

Acquired Immunodeficiency Syndrome (1)

Broader conditions

Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Genital Diseases (1)  ·  HIV Infections (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Infections (1)  ·  Lentivirus Infections (1)  ·  RNA Virus Infections (1)  ·  Retroviridae Infections (1)  ·  Sexually Transmitted Diseases (1)  ·  Sexually Transmitted Diseases, Viral (1)  ·  Slow Virus Diseases (1)  ·  Urogenital Diseases (1)  ·  Virus Diseases (1)

Interventions

Rilpivirine (1)  ·  cabotegravir (1)

Sponsors

Pomeranian Medical University Szczecin (1)

Countries

Czechia (1)  ·  Germany (1)  ·  Poland (1)